Skip to content
HowShorted

Ocugen, Inc. short interest in 2025

In 2025, Ocugen, Inc.'s disclosed short interest ran from 19.26% of shares outstanding on 15 Jan 2025 to 14.85% on 31 Dec 2025, a change of -4.41 percentage points. The year's high was 23.83% on 15 May 2025 and its low 14.85% on 31 Dec 2025, averaging 20.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.02 days on 29 Aug 2025. Full history: Ocugen, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Ocugen, Inc. in 2025

2025 in figures

Start of year
19.26% (15 Jan 2025)
End of year
14.85% (31 Dec 2025)
Change
-4.41 pp
High
23.83% (15 May 2025)
Low
14.85% (31 Dec 2025)
Average
20.34%
Highest days to cover
30.02 (29 Aug 2025)
SEC filings marked
8

Every report in 2025

Ocugen, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202519.26%10.16
31 Jan 202520.21%15.35
14 Feb 202520.68%17.46
28 Feb 202521.86%17.89
14 Mar 202523.18%16.3810-K filed, results (8-K)
31 Mar 202522.58%15.11
15 Apr 202523.57%16.84
30 Apr 202523.42%23.77
15 May 202523.83%21.9910-Q filed, results (8-K)
30 May 202523.45%10.73
13 Jun 202522.32%11.17
30 Jun 202521.65%5.55
15 Jul 202519.22%12.87
31 Jul 202518.73%17.43
15 Aug 202518.89%22.55results (8-K), 10-Q filed
29 Aug 202518.66%30.02
15 Sep 202518.50%21.55
30 Sep 202518.06%6.26
15 Oct 202519.88%7.55
31 Oct 202518.57%17.62
14 Nov 202518.92%15.6110-Q filed, results (8-K)
28 Nov 202519.05%20.54
15 Dec 202518.89%17.14
31 Dec 202514.85%11.37

See also: Ocugen, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.